BRCA2在卵巢肿瘤组织中的表达及临床意义
DOI:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

基金项目:

南京市卫生局重点项目(YKK08118);南京市科技发展项目(200901083)


Expression of BRCA2 in ovarian tumor tissues and its clinical significance
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:乳腺癌易感基因2(breast cancer suscepbility gene 2,BRCA2)是近几年发现的新的抑癌基因,本研究旨在分析BRCA2在卵巢癌组织中的表达及其临床意义-方法:采用1对引物扩增BRCA2基因第14外显子,应用聚合酶链反应和基因测序技术检测BRCA2基因,并且应用免疫组化和Western blot检测肿瘤组织BRCA2蛋白的表达-结果:卵巢黏液性囊腺瘤和正常组织BRCA2基因未发生突变,浆液性肿瘤和黏液性囊腺癌的BRCA2第14外显子的128位碱基T突变为C-Western blot检测结果显示BRCA2在卵巢囊腺癌上的表达低于正常卵巢组织和卵巢囊腺瘤,免疫组化检测结果发现BRCA2在卵巢黏液性囊腺瘤和黏液性囊腺癌中的阳性率分别为87.50%和53.33%,差异有统计学意义(P < 0.05);而BRCA2在卵巢浆液性囊腺瘤和浆液性囊腺癌中阳性率分别为53.85%和73.17%,差异没有统计学意义(P > 0.05)-BRCA2蛋白在不同年龄-组织学分型-分化程度和临床分期各组间差异均无统计学意义(P > 0.05)-结论:BRCA2在卵巢癌组织中的表达不仅可以用于诊断,也可能为治疗提供一个途径-

    Abstract:

    Objective:To analyze expression of breast cancer suscepbility gene 2(BRCA2) in ovarian cancer tissues and its clinical significance. Methods:BRCA2 was detected using a pair of primer on 14 exon of BRCA2 by polymerase chain reaction amplification,and the mutations of BRCA2 were analyzed by DNA sequencing. The expression of BRCA2 protein in ovarian tumor tissues were detected by immunohistochemistry and Western blot. Results:No mutation was found in any mucinous cystadenoma and normal tissues,but the base T of 128 mutated C in 14 exon of BRCA2 in serous tumors and mucinous carcinoma. Western blot showed that BRCA2 protein expression of the malignant tumor in ovarian was lower than that of normal tissues and benign tumors. The results of immunohistochemistry showed that the BRCA2 expression rates in mucinous cystadenoma and mucinous carcinoma were 87.50% and 53.33% respectively,and there were significant differences between the mucinous cystadenoma and mucinous carcinoma (P < 0.05);whereas the BRCA2 expression rates in serous cystadenoma and serous carcinoma were 53.85% and 73.17% respectively,and there was no significant difference between the serous cystadenoma and serous carcinoma(P > 0.05). The BRCA2 expression was not significantly associated with patient’s age,clinical stage,differentiation and histological types of ovarian cancer (P > 0.05). Conclusion:BRCA2 expression in ovarian tumor tissues can be used as a diagnosis marker,it also may provide a target for the ovarian cancer treatment.

    参考文献
    相似文献
    引证文献
引用本文

刘琼琼,张慧林,李 琥,张万东,王小英,李凤山,冯振卿,朱 进. BRCA2在卵巢肿瘤组织中的表达及临床意义[J].南京医科大学学报(自然科学版),2012,(7):995-999

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2011-12-06
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期:
  • 出版日期: